Overview
Georgios Chrysovitsiotis practices in Athens, Greece. Mr. Chrysovitsiotis is rated as a Distinguished expert by MediFind in the treatment of Multiple Symmetric Lipomatosis. His top areas of expertise are Multiple Symmetric Lipomatosis, Familial Multiple Lipomatosis, Nasal Septal Hematoma, and Periorbital Cellulitis.
His clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Multiple Symmetric Lipomatosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple Symmetric LipomatosisMr. Chrysovitsiotis isDistinguished. Learn about Multiple Symmetric Lipomatosis.
- Advanced
- Familial Multiple LipomatosisMr. Chrysovitsiotis isAdvanced. Learn about Familial Multiple Lipomatosis.
- Experienced
- EmphysemaMr. Chrysovitsiotis isExperienced. Learn about Emphysema.
- Nasal Septal HematomaMr. Chrysovitsiotis isExperienced. Learn about Nasal Septal Hematoma.
- Necrotizing FasciitisMr. Chrysovitsiotis isExperienced. Learn about Necrotizing Fasciitis.
- Orbital CellulitisMr. Chrysovitsiotis isExperienced. Learn about Orbital Cellulitis.
- PerichondritisMr. Chrysovitsiotis isExperienced. Learn about Perichondritis.
- Periorbital CellulitisMr. Chrysovitsiotis isExperienced. Learn about Periorbital Cellulitis.